🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
A randomized, prospective study of the efficacy and safety of the first-lin...
Status
Unknown
Location
Multiple Locations
Start Date
2020-05-01
Trial ID
NCT04360655
Treatments Being Tested
This is a phase I study of an agonistic CD40 antibody (mitazalimab) injecte...
Status
Recruiting
Location
UCSD Moores Cancer Center
Start Date
2024-07-17
Trial ID
NCT06205849
Treatments Being Tested
This is a Phase II, multi-site, open-label, parallel group study in partici...
Status
Active Not Recruiting
Location
Alaska Oncology and Hematology, LLC
Start Date
2024-08-05
Trial ID
NCT06449209
Treatments Being Tested
The purpose of this study is to assess the efficacy and safety of RP2 in co...
Status
Recruiting
Location
Beverly Hills Cancer Center
Start Date
2024-08-01
Trial ID
NCT05733598
Treatments Being Tested
This study is a prospective, single-center, phase Ib/II clinical trial desi...
Status
Not Yet Recruiting
Location
Institute of Hematology and Blood Diseases Hospital Chinese Academy of Medical Sciences
Start Date
2026-08-01
Trial ID
NCT07687004
Treatments Being Tested
This study is a prospective, dual arm, open Ib/II phase clinical trial, wit...
Status
Not Yet Recruiting
Location
Tongji Hospital affiliated to Tongji Medical College of Huazhong University of Science & Technology
Start Date
2024-09-30
Trial ID
NCT06592287
Treatments Being Tested
A prospective, single-arm, non-randomized, multi-center, open-label study f...
Status
Terminated
Location
Mayo Clinic Rochester
Start Date
2023-02-01
Trial ID
NCT05583188
This phase II trial studies the effect of avelumab, gemcitabine and carbopl...
Status
Terminated
Location
University of Colorado Hospital
Start Date
2022-08-10
Trial ID
NCT04871529
Treatments Being Tested
This is a phase II, open label, multicenter study in subjects with advanced...
Status
Terminated
Location
Shanghai Pulmonary Hospital
Start Date
2019-05-05
Trial ID
NCT03838848
Treatments Being Tested
This is a multicenter, open-label, single-arm, one-stage, phase II study to...
Status
Active Not Recruiting
Location
UMHAT Sveti Ivan Rilski EAD Department of Medical Oncology
Start Date
2021-08-05
Trial ID
NCT04733118
Treatments Being Tested